Tag drug [more than 800 articles] Export

Recent papers classified by the tag drug.

	KEGG for representation and analysis of molecular networks involving diseases and drugs. [My Copy] Nucleic acids research (30 October 2009) by Minoru Kanehisa, Susumu Goto, Miho Furumichi, Mao Tanabe, Mika Hirakawa posted to pathway kegg drug disease by ptrobajo on 2009-11-05 19:47:55 as
	Zicam-Induced Damage to Mouse and Human Nasal Tissue [My Copy] PLoS ONE, Vol. 4, No. 10. (30 October 2009), e7647. by Jae H. Lim, Greg E. Davis, Zhenshan Wang, et al.Vicky Li, Yuping Wu, Tessa C. Rue, Daniel R. Storm posted to odorant human drug animal by sherdim to the group EPLab on 2009-11-05 14:14:58 as
	The impact of protein biochips and microarrays on the drug development process [My Copy] Drug Discovery Today, Vol. 7, No. 18. (September 2002), pp. S119-S124. by C. Huels posted to peptide microarray drug by VGreiff on 2009-11-05 14:08:28 as
	Systems biology reveals new strategies for personalizing cancer medicine and confirms the role of PTEN in resistance to trastuzumab. [My Copy] Cancer research, Vol. 69, No. 16. (15 August 2009), pp. 6713-6720. by Dana Faratian, Alexey Goltsov, Galina Lebedeva, et al.Anatoly Sorokin, Stuart Moodie, Peter Mullen, Charlene Kay, In Hwa H. Um, Simon Langdon, Igor Goryanin, David J. Harrison posted to mrc dynamic_model drug by schwartzjmc on 2009-11-04 18:50:18 as along with 3 people bertelsen ericrpaquet frohike
	Levetiracetam-induced platelet dysfunction. [My Copy] Epilepsy research, Vol. 86, No. 1. (15 September 2009), pp. 94-96. by Marie Hacquard, Sébastien Richard, Jean-Christophe C. Lacour, Thomas Lecompte, Hervé Vespignani posted to platelets platelet_function platelet_aggregation platelet drugs drug by DavidG67 on 2009-11-04 09:18:52 as
	An amantadine-sensitive chimeric BM2 ion channel of influenza B virus has implications for the mechanism of drug inhibition [My Copy] Proceedings of the National Academy of Sciences, Vol. 106, No. 44. (3 November 2009), pp. 18775-18779. by Yuki Ohigashi, Chunlong Ma, Xianghong Jing, Victoria Balannick, Lawrence H. Pinto, Robert A. Lamb posted to virus influenza drug by zwang on 2009-11-04 09:05:11 as
	Management of blood pressure in primary care. [My Copy] BMJ (Clinical research ed.), Vol. 338, No. may19_1. (19 May 2009), b940. by Richard J. McManus, Jonathan Mant posted to drug bp by guhjy on 2009-11-04 06:29:10 as along with 2 people stempvoort louisagill
	Structure of Protein Interaction Networks and Their Implications on Drug Design [My Copy] PLoS Comput Biol, Vol. 5, No. 10. (30 October 2009), e1000550. by Takeshi Hase, Hiroshi Tanaka, Yasuhiro Suzuki, So Nakagawa, Hiroaki Kitano posted to protein-protein nov09 network drug by nickolay on 2009-11-03 20:45:42 as along with 9 people and 1 group kiekyon kshameer zwang phoenixzxl venancio CorinYeats ess30 poirel jbesnard Orengo Group Journal Picks
	Should we prescribe blood pressure lowering drugs to every patient with advanced chronic kidney disease? A comment on two recent meta-analyses. [My Copy] Polskie archiwum medycyny wewnȩtrznej, Vol. 119, No. 10. (October 2009), pp. 644-647. by Peter Gross, Holger Schirutschke, Kerstin Barnett posted to meta-analysis drug ckd bp by guhjy on 2009-11-03 08:31:11 as
	Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. [My Copy] BMJ (Clinical research ed.), Vol. 338, No. may19_1. (19 May 2009), b1665. by M. R. Law, J. K. Morris, N. J. Wald posted to meta-analysis drug cv bp by guhjy on 2009-11-03 06:02:31 as along with 2 people cardioexe radagabriel
	Pharmacokinetic characteristics of antimicrobials and optimal treatment of urosepsis. [My Copy] Clinical pharmacokinetics, Vol. 46, No. 4. (2007), pp. 291-305. by Florian M. Wagenlehner, Wolfgang Weidner, Kurt G. Naber posted to uti drug by guhjy on 2009-11-03 04:52:38 as
	AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance [My Copy] Vol. 16, No. 5. (6 November 2009), pp. 401-412. by Thomas O'Hare, William C. Shakespeare, Xiaotian Zhu, et al.Christopher A. Eide, Victor M. Rivera, Frank Wang, Lauren T. Adrian, Tianjun Zhou, Wei-Sheng Huang, Qihong Xu, Chester A. Metcalf, Jeffrey W. Tyner, Marc M. Loriaux, Amie S. Corbin, Scott Wardwell, Yaoyu Ning, Jeffrey A. Keats, Yihan Wang, Raji Sundaramoorthi, Mathew Thomas, Dong Zhou, Joseph Snodgrass, Lois Commodore, Tomi K. Sawyer, David C. Dalgarno, Michael W. N. Deininger, Brian J. Druker, Tim Clackson posted to structure resistance leukemia inhibitor drug by renatomilani on 2009-11-03 02:26:41 as
	Systems biology: an evolving approach in drug discovery and development. [My Copy] Drugs in R&D, Vol. 9, No. 4. (2008), pp. 203-216. by R. L. Ho, C. A. Lieu posted to systems f1000 drug by renatomilani on 2009-11-03 00:36:06 as along with 1 person flbarroso
	Coevolutionary analysis of resistance-evading peptidomimetic inhibitors of HIV-1 protease. [My Copy] Proceedings of the National Academy of Sciences of the United States of America, Vol. 96, No. 4. (16 February 1999), pp. 1369-1374. by C. D. Rosin, R. K. Belew, G. M. Morris, A. J. Olson, D. S. Goodsell posted to inhibitor drug by jjurban on 2009-11-02 22:03:46 as
	Molecular recognition of macrocyclic peptidomimetic inhibitors by HIV-1 protease. [My Copy] Biochemistry, Vol. 38, No. 25. (22 June 1999), pp. 7978-7988. by J. L. Martin, J. Begun, A. Schindeler, et al.W. A. Wickramasinghe, D. Alewood, P. F. Alewood, D. A. Bergman, R. I. Brinkworth, G. Abbenante, D. R. March, R. C. Reid, D. P. Fairlie posted to inhibitor drug by jjurban on 2009-11-02 22:03:45 as
	A peptide inhibitor of HIV-1 protease using alpha, beta- dehydro residues: a structure based computer model. [My Copy] Indian journal of biochemistry & biophysics, Vol. 38, No. 1-2. (r 2001), pp. 90-95. by M. I. Siddiqui, S. Kataria, V. Ahuja, G. S. Rao posted to inhibitor drug by jjurban on 2009-11-02 22:03:45 as
	Free energy component analysis for drug design: a case study of HIV-1 protease-inhibitor binding. [My Copy] Journal of medicinal chemistry, Vol. 44, No. 25. (6 December 2001), pp. 4325-4338. by P. Kalra, T. V. Reddy, B. Jayaram posted to inhibitor drug by jjurban on 2009-11-02 22:03:45 as
	Computational study of the catalytic domain of human neutrophil collagenase. specific role of the S3 and S'3 subsites in the interaction with a phosphonate inhibitor. [My Copy] Journal of computer-aided molecular design, Vol. 16, No. 3. (March 2002), pp. 213-225. by Massimiliano Aschi, Danilo Roccatano, Alfredo Di Nola, et al.Carlo Gallina, Enrico Gavuzzo, Giorgio Pochetti, Michael Pieper, Harald Tschesche, Fernando Mazza posted to inhibitor drug by jjurban on 2009-11-02 22:03:45 as
	Design and synthesis of o-trifluoromethylbiphenyl substituted 2-amino-nicotinonitriles as inhibitors of farnesyltransferase. [My Copy] Bioorganic & medicinal chemistry letters, Vol. 15, No. 1. (3 January 2005), pp. 153-158. by Gary T. Wang, Xilu Wang, Weibo Wang, et al.Lisa A. Hasvold, Gerry Sullivan, Charles W. Hutchins, Steve O'Conner, Robert Gentiles, Thomas Sowin, Jerry Cohen, Wen-Zhen Z. Gu, Haiying Zhang, Saul H. Rosenberg, Hing L. Sham posted to inhibitor drug by jjurban on 2009-11-02 22:03:45 as
	Protein farnesyltransferase: flexible docking studies on inhibitors using computational modeling. [My Copy] Journal of computer-aided molecular design, Vol. 19, No. 12. (December 2005), pp. 871-885. by Wayne C. Guida, Andrew D. Hamilton, Justin W. Crotty, Saïd M. Sebti posted to inhibitor drug by jjurban on 2009-11-02 22:03:45 as
	Design, synthesis, and evaluation of 3C protease inhibitors as anti-enterovirus 71 agents. [My Copy] Bioorganic & medicinal chemistry, Vol. 16, No. 15. (1 August 2008), pp. 7388-7398. by Chih-Jung J. Kuo, Jiun-Jie J. Shie, Jim-Min M. Fang, et al.Guei-Rung R. Yen, John T-A T. Hsu, Hun-Ge G. Liu, Sung-Nain N. Tseng, Shih-Cheng C. Chang, Ching-Yin Y. Lee, Shin-Ru R. Shih, Po-Huang H. Liang posted to inhibitor drug by jjurban on 2009-11-02 22:03:45 as
	Design of peptidomimetic inhibitors of aspartic protease of HIV-1 containing -Phe Psi Pro- core and displaying favourable ADME-related properties. [My Copy] Journal of molecular graphics & modelling, Vol. 27, No. 3. (October 2008), pp. 376-387. by Vladimir Frecer, Federico Berti, Fabio Benedetti, Stanislav Miertus posted to inhibitor drug by jjurban on 2009-11-02 22:03:45 as
	Thermodynamic and computational studies on the binding of p53-derived peptides and peptidomimetic inhibitors to HDM2. [My Copy] Chembiochem : a European journal of chemical biology, Vol. 10, No. 8. (25 May 2009), pp. 1360-1368. by Anja Grässlin, Celine Amoreira, Kim K. Baldridge, John A. Robinson posted to inhibitor drug by jjurban on 2009-11-02 22:03:45 as
	Should proteinuria reduction be the criterion for antihypertensive drug selection for patients with kidney disease? [My Copy] Current opinion in nephrology and hypertension, Vol. 18, No. 5. (September 2009), pp. 386-391. by Rigas G. Kalaitzidis, George L. Bakris posted to proteinuria drug ckd bp by guhjy on 2009-11-02 10:20:41 as
	Chronic Calcineurin Inhibitor Nephrotoxicity: Reflections on an Evolving Paradigm. [My Copy] Clinical journal of the American Society of Nephrology : CJASN (22 October 2009) by Robert S. Gaston posted to rt drug csa by guhjy on 2009-11-02 10:12:20 as
	Current approaches to the use of sirolimus in renal transplantation. [My Copy] Transplantation proceedings, Vol. 41, No. 8. (October 2009), pp. 3011-3015. by B. D. Kahan posted to rt drug by guhjy on 2009-11-02 10:11:45 as
	Calcineurin inhibitor sparing immunosuppressive regimens in kidney allograft recipients. [My Copy] Polskie archiwum medycyny wewnȩtrznej, Vol. 119, No. 5. (May 2009), pp. 318-325. by Teresa Baczkowska, Magdalena Durlik posted to rt drug by guhjy on 2009-11-02 10:10:36 as
	Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity. [My Copy] Clinical transplantation, Vol. 22, No. 1. (February 2008), pp. 1-15. by Stuart M. Flechner, Jon Kobashigawa, Goran Klintmalm posted to rt drug by guhjy on 2009-11-02 10:10:05 as
	Immunosuppressive treatment options in renal transplantation. [My Copy] Minerva urologica e nefrologica = The Italian journal of urology and nephrology, Vol. 57, No. 3. (September 2005), pp. 141-149. by G. Ciancio, G. W. Burke, D. Jorge, A. Rosen, J. Miller posted to rt drug by guhjy on 2009-11-02 10:08:32 as
	Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study. [My Copy] Health technology assessment (Winchester, England), Vol. 9, No. 21. (May 2005) by R. Woodroffe, G. L. Yao, C. Meads, et al.S. Bayliss, A. Ready, J. Raftery, R. S. Taylor posted to rt drug by guhjy on 2009-11-02 04:51:13 as
	Pharmacology of calcineurin antagonists [My Copy] Transplantation Proceedings, Vol. 36, No. 2. (March 2004), pp. S25-S32. by M. Kapturczak posted to rt drug by guhjy on 2009-11-02 04:49:44 as
	An up-date review on individualized dosage adjustment of calcineurin inhibitors in organ transplant patients. [My Copy] Pharmacology & therapeutics, Vol. 112, No. 1. (October 2006), pp. 184-198. by Satohiro Masuda, Ken-ichi Inui posted to rt drug by guhjy on 2009-11-02 04:46:08 as
	Tacrolimus: a further update of its use in the management of organ transplantation. [My Copy] Drugs, Vol. 63, No. 12. (2003), pp. 1247-1297. by Lesley J. Scott, Kate McKeage, Susan J. Keam, Greg L. Plosker posted to rt drug by guhjy on 2009-11-02 04:44:51 as
	Calcineurin inhibitors in renal transplantation: what is the best option? [My Copy] Drugs, Vol. 63, No. 15. (2003), pp. 1535-1548. by Kazunari Tanabe posted to rt drug by guhjy on 2009-11-02 04:43:56 as
	Can literature analysis identify innovation drivers in drug discovery? [My Copy] Nat Rev Drug Discov, Vol. 8, No. 11. (01 November 2009), pp. 865-878. by Pankaj Agarwal, David B. Searls posted to literature innovation drug discovery citation by nicklynch on 2009-11-01 20:19:31 as along with 1 person dullhunk
	Knowledge-Based Approach to de Novo Design Using Reaction Vectors [My Copy] Journal of Chemical Information and Modeling, Vol. 49, No. 5. (22 May 2009), pp. 1163-1184. by Hina Patel, Michael J. Bodkin, Beining Chen, Valerie J. Gillet posted to workflow knowledge drug design cheminformatics by nicklynch on 2009-10-26 13:22:32 as along with 1 person alfons
	A Breath of Fresh Air? Firm Type, Scale, Scope, and Selection Effects in Drug Development [My Copy] MANAGEMENT SCIENCE, Vol. 55, No. 10. (1 October 2009), pp. 1638-1653. by Ashish Arora, Alfonso Gambardella, Laura Magazzini, Fabio Pammolli posted to type selection scope scale fresh firm effects drug development breath air by derchao on 2009-10-20 17:42:20 as
	Keeping Modern in Medicine: Pharmaceutical Promotion and Physician Education in Postwar America [My Copy] Bulletin of the History of Medicine, Vol. 83, No. 2. (2009), pp. 331-377. by Jeremy A. Greene, Scott H. Podolsky posted to industry history drug cme by jsydc on 2009-10-19 18:17:42 as
	Conflicts of interest in pain medicine: Practice patterns and relationships with industry [My Copy] Pain, Vol. 139, No. 3. (31 October 2008), pp. 494-497. by J. Schofferman, J. Banja posted to pain industry drug by jsydc on 2009-10-19 18:13:20 as
	Harnessing gene expression to identify the genetic basis of drug resistance [My Copy] Molecular Systems Biology, Vol. 5 (13 October 2009) by Bo-Juen Chen, Helen C. Causton, Denesy Mancenido, Noel L. Goddard, Ethan O. Perlstein, Dana Pe'er posted to resistance identification genetic gene expression drug basis by dswan on 2009-10-16 09:03:31 as along with 4 people ashishanand phoenixzxl ptrobajo frohike
	Drug-therapy networks and the prediction of novel drug targets [My Copy] Journal of Biology, Vol. 7, No. 6. (31 July 2008), 20. by Zoltan Spiro, Istvan Kovacs, Peter Csermely posted to drug by schwartzjmc on 2009-10-15 15:07:29 as
	Identification of Novel Kinase Targets for the Treatment of Estrogen ReceptorâNegative Breast Cancer [My Copy] Clinical Cancer Research, Vol. 15, No. 20. (15 October 2009), pp. 6327-6340. by Corey Speers, Anna Tsimelzon, Krystal Sexton, et al.Ashley M. Herrick, Carolina Gutierrez, Aedin Culhane, John Quackenbush, Susan Hilsenbeck, Jenny Chang, Powel Brown posted to for:jfr kinase estrogen_receptor drug breast_cancer by frohike on 2009-10-15 08:28:09 as
	The Body Hunters: How the Drug Industry Tests Its Products on the World's Poorest Patients [My Copy] JAMA, Vol. 296, No. 17. (1 November 2006), pp. 2149-2150. by Thomas A. Faunce posted to testingpoor industry drug by ticakim on 2009-10-14 07:18:51 as
	Child Protection Outcomes for Infants of Substance-Using Mothers: A Matched-Cohort Study [My Copy] Pediatrics, Vol. 124, No. 1. (1 July 2009), pp. 285-293. by Andrea McGlade, Robert Ware, Maree Crawford posted to use drug child abuse by JoelJacobsen on 2009-10-13 20:54:39 as
	High-Performance Drug Discovery: Computational Screening by Combining Docking and Molecular Dynamics Simulations [My Copy] PLoS Comput Biol, Vol. 5, No. 10. (9 October 2009), e1000528. by Noriaki Okimoto, Noriyuki Futatsugi, Hideyoshi Fuji, et al.Atsushi Suenaga, Gentaro Morimoto, Ryoko Yanai, Yousuke Ohno, Tetsu Narumi, Makoto Taiji posted to optimization molecular_dynamics_simulations md_simulations md drug_discovery drug docking by skywalkerus02 on 2009-10-12 07:05:35 as along with 5 people and 1 group ibuch klexa kentsis reyez barry McCammon
	Treatment of overweight and obesity: lifestyle, pharmacologic, and surgical options. [My Copy] Clinical cornerstone, Vol. 9, No. 4. (2009) by Christopher P. Cannon, Amit Kumar posted to treatment obesity exercise drug by samueleuk on 2009-10-11 08:54:12 as
	A Mapping of Drug Space from the Viewpoint of Small Molecule Metabolism [My Copy] PLoS Comput Biol, Vol. 5, No. 8. (21 August 2009), e1000474. by James C. Adams, Michael J. Keiser, Li Basuino, et al.Henry F. Chambers, Deok-Sun Lee, Olaf G. Wiest, Patricia C. Babbitt posted to nov09 target similarity network metabolism ligand drug action by nickolay on 2009-10-08 19:20:47 as along with 8 people and 1 group sobolevnrm klexa bdessailly pablocarb ptrobajo biomcgary reyez thomaskelder Orengo Group Journal Picks
	Quantifying the Relationships among Drug Classes [My Copy] Journal of Chemical Information and Modeling, Vol. 48, No. 4. (1 April 2008), pp. 755-765. by Jérôme Hert, Michael J. Keiser, John J. Irwin, Tudor I. Oprea, Brian K. Shoichet posted to nov09 similarity-network ligand drug clustering by nickolay on 2009-10-08 19:11:43 as along with 8 people and 1 group tjchen mijogiffin pauldobson dullhunk middledomain sobolevnrm ucbcjbm jerome_ucsf_slb baker-group
	Hetero-oligomerization of CCR2, CCR5 and CXCR4 and the protean effects of "selective"-antagonists. [My Copy] The Journal of biological chemistry (15 September 2009) by Denis Sohy, Hideaki Yano, Patricia de Nadai, et al.Eneko Urizar, Aude Guillabert, Jonathan A. Javitch, Marc Parmentier, Jean-Yves Y. Springael posted to oligomerization drug chemokine antagonist by xdeupi on 2009-10-06 19:26:05 as
	Computational analysis of membrane proteins: the largest class of drug targets. [My Copy] Drug discovery today (3 September 2009) by Yalini Arinaminpathy, Ekta Khurana, Donald M. Engelman, Mark B. Gerstein posted to theory membrane_proteins drug by xdeupi on 2009-10-06 19:23:18 as

Note: You may cite this page as: http://www.citeulike.org/tag/drug

Result page: 1 2 3 4 5 6 7 8 9 10 Next

review	152
discovery	111
cancer	85
docking	80
protein	70
ligand	52
resistance	50
pharmacology	48
design	46
disease	43
structure	41
network	40
ligands	37
delivery	33
inhibitor	33
binding	32
effect	31
algorithms	30
target	30
kinase	28
targeting	28
hiv	27
interaction	26
treatment	26
therapy	25
agonist	22
bioinformatics	22
b2ar	21
malaria	21
database	20
genome	20
gpcr	19
db	18
nmr	18
pathway	18
depression	17
activation	16
expression	15
influenza	15
targets	15
adhd	14
bipolar	14
hts	14
yeast	14
addiction	13
biology	13
drugs	13
medication	13
rheumatoid-arthritis	13
rt	13
chemical	12
drug-discovery	12
drugdiscovery	12
function	12
gene	12
herb	12
leukemia	12
metabolism	12
views	12
apoptosis	11
cheminformatics	11
dna	11
modeling	11
polymorphism	11
receptor	11
rna	11
side_effects	11
small	11
based	10
bp	10
cognitive	10
cv	10
development	10
mechanism	10
methods	10
microarray	10
model	10
molecule	10
prediction	10
screening	10
similarity	10
systems-biology	10
virus	10
adverse	9
ckd	9
evolution	9
gene-expression	9
schizophrenia	9
screen	9
transporter	9
abuse	8
bacteria	8
drug-binding	8
dysphagia	8
imaging	8
ma	8
proteomics	8
psychosis	8
sensitivity	8
signature	8

Tag drug [more than 800 articles] Export

Related Tags